Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
Blood
|
July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial
T Petrella, C Copie-Bergman, J Brière, et al.
Leukemia
|
August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
X Thomas, P Fenaux, H Dombret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party
I El-Najjar, A Boumendil, J J Luan, et al.
Bone Marrow Transplantation
|
April 26, 2016
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
B Tessoulin, P Ceballos, P Chevallier, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
Bone Marrow Transplantation
|
April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
A Stamatoullas, P Brice, M S Gueye, et al.
Bone Marrow Transplantation
|
May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
L Bento, A Boumendil, H Finel, et al.
The New England Journal of Medicine
|
August 10, 2012
Treatment of older patients with mantle-cell lymphoma
H C Kluin-Nelemans, E Hoster, O Hermine, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
Blood
|
July 14, 2017
FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study
R-O Casasnovas, L Ysebaert, C Thieblemont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 23, 2017
BCL2 expression but not MYC and BCL2 coexpression predicts survival in elderly patients with diffuse large B-cell lymphoma independently of cell of origin in the phase 3 LNH03-6B trial
T Petrella, C Copie-Bergman, J Brière, et al.
Leukemia
|
August 18, 1999
Granulocyte-macrophage colony-stimulating factor (GM-CSF) to increase efficacy of intensive sequential chemotherapy with etoposide, mitoxantrone and cytarabine (EMA) in previously treated acute myeloid leukemia: a multicenter randomized placebo-controlled trial (EMA91 Trial)
X Thomas, P Fenaux, H Dombret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 7, 2014
The impact of total body irradiation on the outcome of patients with follicular lymphoma treated with autologous stem-cell transplantation in the modern era: a retrospective study of the EBMT Lymphoma Working Party
I El-Najjar, A Boumendil, J J Luan, et al.
Bone Marrow Transplantation
|
April 26, 2016
Allogeneic stem cell transplantation for patients with mantle cell lymphoma who failed autologous stem cell transplantation: a national survey of the SFGM-TC
B Tessoulin, P Ceballos, P Chevallier, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
Bone Marrow Transplantation
|
April 5, 2016
Autologous stem cell transplantation for patients aged 60 years or older with refractory or relapsed classical Hodgkin's lymphoma: a retrospective analysis from the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC)
A Stamatoullas, P Brice, M S Gueye, et al.
Bone Marrow Transplantation
|
May 23, 2017
Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party
L Bento, A Boumendil, H Finel, et al.
The New England Journal of Medicine
|
August 10, 2012
Treatment of older patients with mantle-cell lymphoma
H C Kluin-Nelemans, E Hoster, O Hermine, et al.
Page
of 16